BioLineRx Announces FDA Approval of IND Application for AGI-134, a Novel Immunotherapy Anti-Cancer Vaccine for Solid Tumors

Stock Information for BioLineRx Ltd.

Loading

Please wait while we load your information from QuoteMedia.